Login

Let's Talk About Your Organization's Retirement Plan | Rene Bruner - Advisor of smith bruer advisors 00:10:00

Share On Facebook Share On Twitter

Rene Bruner is the CFP and Advisor of smith bruer advisors

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Rising Energy Prices: Impact on the Economy and Consumers
00:10:00
Navoi Mining: Uzbekistan's Leading Gold Producer and Expansion Plans
00:10:00
Talks about how to deal with a remote work environment, cyber security and ESG|CEO , Blackbaud Inc
00:10:00
Q&A with Neal Barclay, CEO of Meridian Energy, on European politics' impact discussed in Craigs Investment Partners' Weekly Update.
00:10:00
Robert Ogór on Navigating Cost Increases and Future Challenges at AMBRA SA | Robert Ogór, President, AMBRA SA.
00:10:00
Compound vs Simple Interest: Understanding the Difference | Mike Murkins - Financial Planner of Syverson Strege
00:00:00
Martha Grogan, M.D. Cardiologist, Mayo Clinic / Why early diagnosis and targeted treatment matter
00:10:00
Red Pine Exploration's Drilling and Growth Plans
00:10:00
Interview with Ian Harris, President and CEO of Libero Copper & Gold
00:10:00
A General Guide to IRS Audits | Vince Carson - Tax Specialist at Howe & Rusling
00:10:00
focused on exceptional founders building machine intelligence and data companies|Brendan Kohler,Co-founder,Hyperplane Venture Capital
00:10:00
Poh Yee Tiong, our Head of Asia-Pacific spoke about Procurri’s “cradle-to-grave” approach to IT infrastructure, which provides a one-stop fulfilment for cloud and managed service providers|Mat Jordan,CEO,Procurri Corporation Ltd

© 2017 - Neuhu+